[1] OTHMAN M,KAUR H.Thromboelastography (TEG)[J].Methods Mol Biol,2017,1646:533-543. [2] WIKKELSØ A,WETTERSLEV J,MØLLER A M,et al.Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding[J].Cochrane Database Syst Rev,2016(8):CD007871. [3] GONZALEZ E,MOORE E E,MOORE H B.Ma-nagement of trauma-induced coagulopathy with thrombelastography[J].Crit Care Clin,2017,33(1):119-134. [4] CHAPIN J C,HAJJAR K A.Fibrinolysis and the control of blood coagulation[J].Blood Rev,2015,29(1):17-24. [5] RANDI A M,SMITH K E,CASTAMAN G.Von Willebrand factor regulation of blood vessel formation[J].Blood,2018,132(2):132-140. [6] LÖF A,MÜLLER J P,BREHM M A.A biophysical view on von Willebrand factor activation[J].J Cell Physiol,2018,233(2):799-810. [7] SEDGWICK P.Spearman's rank correlation coefficient[J].BMJ,2014,349:g7327. [8] NASCIMENTO B,AL MAHOOS M,CALLUM J,ET AL.Vitamin K-dependent coagulation factor deficiency in trauma:a comparative analysis between international normalized ratio and thromboelastography (CME)[J].Transfusion,2012,52(1):7-13. [9] WOOLLEY T,MIDWINTER M,SPENCER P,et al.Utility of interim ROTEM® values of clot strength,A5 and A10,in predicting final assessment of coagulation status in severely injured battle patients[J].Injury,2013,44(5):593-599. |